ID: ALA2311915

Max Phase: Preclinical

Molecular Formula: C6H12FNO2

Molecular Weight: 149.17

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](F)[C@@H](N)CCC(=O)O

Standard InChI:  InChI=1S/C6H12FNO2/c1-4(7)5(8)2-3-6(9)10/h4-5H,2-3,8H2,1H3,(H,9,10)/t4-,5-/m0/s1

Standard InChI Key:  BRMXCZLHKCLKIJ-WHFBIAKZSA-N

Associated Targets(non-human)

Gamma-amino-N-butyrate transaminase 192 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 149.17Molecular Weight (Monoisotopic): 149.0852AlogP: 0.54#Rotatable Bonds: 4
Polar Surface Area: 63.32Molecular Species: ZWITTERIONHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.42CX Basic pKa: 9.23CX LogP: -2.21CX LogD: -2.21
Aromatic Rings: 0Heavy Atoms: 10QED Weighted: 0.61Np Likeness Score: 0.32

References

1. Juncosa JI, Groves AP, Xia G, Silverman RB..  (2013)  Probing the steric requirements of the γ-aminobutyric acid aminotransferase active site with fluorinated analogues of vigabatrin.,  21  (4): [PMID:23306054] [10.1016/j.bmc.2012.12.009]

Source